Sustained Disease Control with TOMOXIRI Regimen in a Patient with Metastatic Pancreatic Adenocarcinoma

被引：0
|
作者：
Sara De Dosso
Patrizia Melchiorre
Chiara Della Badia
Giorgio Moschovitis
Piercarlo Saletti
机构：
[1] Oncology Institute of Southern Switzerland,Medical Oncology Department
[2] Ospedale Regionale di Lugano,Cardiology Unit, Internal Medicine Department
来源：
Journal of Gastrointestinal Cancer | 2015年 / 46卷 / 3期
关键词：
Gemcitabine; Irinotecan; Oxaliplatin; Raltitrexed; Reduce Folate Carrier;
D O I：
10.1007/s12029-015-9705-4
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：327 / 331
页数：4
相关论文
共 50 条
  • [31] Treatment of Metastatic Pancreatic Adenocarcinoma: A Review
    Thota, Ramya
    Pauff, James M.
    Berlin, Jordan D.
    ONCOLOGY-NEW YORK, 2014, 28 (01): : 70 - 74
  • [32] Therapeutic Approaches for Metastatic Pancreatic Adenocarcinoma
    Rubinson, Douglas A.
    Wolpin, Brian M.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2015, 29 (04) : 761 - +
  • [33] Metastatic Pancreatic Adenocarcinoma During Pregnancy
    Davis, Jessica
    Bashir, Showkat
    Wubneh, Helmae
    Borum, Marie L.
    ACG CASE REPORTS JOURNAL, 2016, 3 (04)
  • [34] Mutational Landscape of Metastatic Pancreatic Adenocarcinoma
    Beg, Shaham
    Jessurun, Jose
    Rao, Rema A.
    Robinson, Brian
    Sboner, Andrea
    Elemento, Olivier
    Beltran, Himisha
    Mosquera, Juan Miguel
    MODERN PATHOLOGY, 2018, 31 : 672 - 673
  • [35] Mouse models of metastatic pancreatic adenocarcinoma
    Xie, KP
    Wang, BL
    Shi, Q
    Abbruzzese, JL
    Xiong, QH
    Le, XD
    INTERNATIONAL JOURNAL OF PANCREATOLOGY, 2001, 29 (01) : 25 - 35
  • [36] Sustained Stable Disease with Capecitabine plus Bevacizumab in Metastatic Appendiceal Adenocarcinoma: A Case Report
    Arias Ron, David
    Labandeira, Carmen M.
    Cameselle Garcia, Soledad
    Garcia Mata, Jesus
    Salgado Fernandez, Mercedes
    CASE REPORTS IN ONCOLOGY, 2020, 13 (01): : 69 - 75
  • [37] A correlative analysis of biochemical and radiologic hepatic disease in metastatic pancreatic adenocarcinoma (PA).
    McHugh, Deaglan Joseph
    Teo, MinYuen
    Rozumna-Martynyuk, Nataliya
    McDermott, Raymond S.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [38] Incidence and risk factors for abdominal occult metastatic disease in patients with pancreatic adenocarcinoma
    Gemenetzis, Georgios
    Groot, Vincent P.
    Blair, Alex B.
    Ding, Ding
    Thakker, Sameer S.
    Fishman, Elliot K.
    Cameron, John L.
    Makary, Martin A.
    Weiss, Matthew J.
    Wolfgang, Christopher L.
    He, Jin
    JOURNAL OF SURGICAL ONCOLOGY, 2018, 118 (08) : 1277 - 1284
  • [39] Pearls and pitfalls of imaging metastatic disease from pancreatic adenocarcinoma: a systematic review
    Zaheer, Atif
    Wadhwa, Vibhor
    Oh, Joseph
    Fishman, Elliot K.
    CLINICAL IMAGING, 2015, 39 (05) : 750 - 758
  • [40] Progression of KRAS mutant pancreatic adenocarcinoma during vemurafenib treatment in a patient with metastatic melanoma
    Grey, A.
    Cooper, A.
    McNeil, C.
    O'Toole, S.
    Thompson, J.
    Grimison, P.
    INTERNAL MEDICINE JOURNAL, 2014, 44 (06) : 597 - 600
12345